intRoDuction Chronic kidney disease (CKD) is a worldwide public health problem characterized by progressive decrease in kidney function. 1 Early and accurate diagnosis of CKD patients is critical for early prediction of outcome and individualized therapies. 2 CKD staging can benefit accurate diagnosis, therefore appropriate intervention can be adopted at early stage to delay the progression of CKD. 3, 4 Serum markers such as creatinine and blood urea nitrogen levels and estimated glomerular rate (eGFR) are useful parameters for estimating renal function in clinical practice. 5 However, these indicators only assess the global renal function and cannot reflect morphological changes of kidney. The routine radiological methods of detecting CKD, such as ultrasonography (US), CT and MRI, only provide anatomic images without functional information. 6 With regard to contrast enhancement, contrast agents in CT and gadolinium-based MRI may cause nephrotoxicity and systemic nephrogenic fibrosis respectively, thereby limiting their use in CKD patients. 7 Radioisotope scintigraphy is the only established imaging modality to assess renal function by measuring glomerular filtration rate (GFR), but it leads to radiation exposure and has low spatial resolution. So it is necessary to find non-invasive imaging method to quantitatively evaluate renal function of CKD patients.
Diffusion-weighted imaging (DWI) shows the Brownian motion of water molecules in biological tissue, which is usually quantified by the apparent diffusion coefficient (ADC) and provide information on diffusion and perfusion. DWI has been used as a promising modality to assess renal function. [8] [9] [10] [11] [12] [13] Some studies have indicated the The existing findings about the relationship between ADC values and CKD stage are controversial in the previous studies, and in order to address this issue, a meta-analysis was conducted based on high quality published studies to determine the potential value of DWI imaging in the staging of CKD.
metHoDS anD mateRiaLS
This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)statement (Supplementary Material 1). This meta-analysis did not involve identifiable patient information, so no particular ethical consideration was required.
Literature search
Databases were searched from PubMed, Web of science, Cochrane and Embase to identify all the relevant articles characterizing the relationship between ADC and the staging of CKD between 1999 and 2017. The following search terms were used "DWI", "diffusion weighted imaging", "ADC" "apparent diffusion coefficient", "CKD", "chronic renal disease", "chronic kidney disease", "magnetic resonance imaging" and "MRI".
Eligibility criteria for study selection Two investigators screened the titles and abstracts from the databases.
The following inclusion criteria for studies were applied:
(1) The population consisted of healthy subjects and CKD patients on native kidneys which based on the K/DOQI (kidney disease outcomes quality initiative) classification.
16
ADC values based on DWI was assessed. The exclusion criteria were as follows:
(1) Review articles, letters, and researches on animal models, comments and case reports. Data extraction and assessment of quality Two authors extracted data independently, and disagreements between them were solved by discussion and consultation with a third author. For accuracy analyses, data were extracted from included studies: such as authors, year of publication, baseline information about the patients, sample size, MR scanner, the equation of eGFR, and the ROI (region of interest) disposition.
We used the standard quality assessment of diagnostic studies (QUADAS-2) tool to assess the quality of included studies, which were classified as low risk of bias, unclear risk of bias or high risk of bias. 17 
Statistical analysis
To compare ADC values between different stages of CKD in different studies, the pooled mean and standard deviation (SD) of ADC were calculated by the following equations:
M and SD are the pooled mean and standard deviation of Group 1 and Group 2 (grouped by stage of eGFR). N1, M1, and SD1 are the size, mean, and standard deviation of Group 1, respectively; N2, M2, and SD2 are the size, mean, and standard deviation of Group 2, respectively.
The ADC value was estimated by the weighted mean difference (WMD) with 95% confidence intervals (CI) by STATA 12.0 (USA). We evaluated the heterogeneity of the individual studies through Cochrane's Q test and calculating the inconsistency index (I-squared, I
2 ) statistics. If p < 0.1, it is considered significant heterogeneity between the statistics. 19 It is assigned adjectives of low, moderate, and high to I 2 values of 25%, 50%, and 75%. If I 2 <25%, the fixed effect model was applied for meta-analysis; If 25% < I 2 < 50%, random effect model was applied; If I 2 >50%, the heterogeneity was analyzed first, and the random effect model were used under the circumstances that the source of heterogeneity cannot be found. Egger's test was performed to assess publication bias, and with existence of an inverted symmetrical funnel plot with p > 0.05 was considered evidence of insignificant publication bias.
ReSuLtS

Study selection
After reviewing the titles and abstracts of all searched articles, 146 articles were excluded. There were 11 full-text articles were assessed for eligibility, and 5 articles were excluded for the following reasons: the stages of CKD were not based on the eGFR at the basis of K/QODI; DWI was combined with other MRI techniques; data could not be extracted from the studies. Finally, 6 eligible studies were included in this meta-analysis 10,12,13,15,20,21 ( Figure 1 ). The basic characteristics of included studies are shown in Table 1 .
Assessment of study quality
The quality of included studies was assessed according to the QUADAS-2 items. 17 The results of quality assessment are presented in Figure 2 . The risk of all articles was low because the index test and the reference tests were mutually independent. Some unclear risks from several studies were caused by the different reference standards for CKD diagnosis, including the pathology, the clinical and laboratorial factors, and different equations of eGFR.
Apparent diffusion coefficient distinguished stage 1-2 of CKD from the normal kidneys Detailed data of six studies for pooled weighted mean difference model were shown in Table 2 . There were 561 subjects: 131 healthy volunteers and 430 CKD patients. The ADC values were compared between the healthy subjects and 
DiScuSSion
This meta-analysis showed that DWI is a useful imaging method to evaluate renal function. Furthermore, by comparing ADC 22 There is no standard DWI scanning method at ) significantly affected signals by perfusion effects, leading to inaccurate reflection of water diffusion motion, 23 while high b values carry the risk of distortion and susceptibility artifacts. Variability in b values makes it difficult to interpret its range, however, all meta-analyzed studies had high b values of at least 400 s mm -2 at 1.5T. Therefore, heterogeneity in performance were unlikely resulted from perfusion effects, which were seen mostly at lower b values of 250 s mm -2 or less. 24 Included studies in our meta-analysis were of high quality and showed no publication bias. of the nephron, interstitial fibrosis, tubular atrophy, and scarring of glomeruli. These pathological changes always cause a decline of perfusion, as well as diffusion restriction due to fibrosis. 25 Moreover, the reduced ADC values of early Stage 1-2 in CKD compared with the healthy group suggests that ADC value might reflect the changes of kidney function and further could serve as a non-invasive and effective index to guide therapy and monitor CKD patients in follow-up. Additionally, the pooled data did not suggest significant difference between Stage 3 and Stage 1-2, which is consistent with previous studies by Carbone et al 20 These results might be attributed to the fact that the pathological changes of CKD Stage 1-2 are similar to those of Stage 3. 12 Besides, our meta-analysis shows a significant decrease of ADC values along with the increase of CKD stages, which is consistent with the previous studies. 12, 14 Hence, DWI might be a promising non-invasive technique to monitor the changes of renal function.
Causes of CKD include diabetes, high blood pressure, glomerulonephritis and various chronic renal inflammation. These lead to different renal pathology which is important in guiding therapy. Qing Li et al 26 analyzed the renal ADC values of differentiate CKD pathology types, including IgA nephropathy, focal segmental proliferative glomerulonephritis, and membranous nephropathy. They reported no significant differences in ADC values among the various pathology types. Different pathology types of CKD might share similar pathogenic features, such as hypoxia, chronic renal inflammation and renal fibrosis at last. So the changes of ADC values reflect severity of renal pathology and have clinical potential for assessing the renal function. Meanwhile, DWI is regarded as a functional MRI technique and could obtain the single and spatial information of kidney function, especially in CKD patients with renal tumors who need nephro-sparing surgery. DWI technique not only could evaluate kidney function, but also could provide clinical benefit to choice of treatment strategy for CKD patients. However, various renal pathologies with acute renal infection and inflammatory nephritis could also cause the decrease of ADC values. Hueper et al 27 researched the acute kidney injury in mice by T2 relaxation and ADC values. They reported that ADC values decreased significantly at the beginning (day 0-day 1) and then presented with an increasing trend (day 1-day 28). ADC values decreased with the severity of renal fibrosis 4 weeks after acute kidney injury. Measurement of the dynamic change in ADC values may provide more information to differentiate acute kidney injury from CKD. Further researches are needed to identify the variation of ADC values in human with acute kidney injury.
This meta-analysis has several limitations: First, the number of included literatures is limited and sample size is small, so it is not possible to calculate ROC curves and reliable threshold values. Second, considerable heterogeneity was identified among the included studies and the different measurement methods. Difference in MRI scanner vendors, magnetic field intensity and choice of b values may contribute to study heterogeneity, which should be clarified in further studies. Third, the eGFR is recognized as clinical indicator of renal function and used for CKD staging. The eGFR was calculated from several different equations in lots of studies, which may cause the heterogeneity.
In conclusion, this meta-analysis provides evidence for DWI as a non-invasive method in the assessment of renal function in CKD. DWI can differentiate early stage of CKD from normal kidney and determine stages of CKD quantitatively using ADC values. 
